SUN PHARMACEUTICAL INDUSTRIES Q4 FY 05-06 NET UP 38.17% TO RS 1428.5 MN

Sun Pharma recorded the considerable increment of 46% in its (unaudited) net profit to Rs 1158.9 mn in Q4 FY 2005-06 compared to the same period of 2004-05. The total income(unaudited) grew by 32.79% to the Rs 4544.30 million in Q4 FY 2005-06.

Myiris (http://www.myiris.com/newsCentre/storyShow.php?fileR=20060607105444091&secID=fromnewsroom&secTitle=From%20the%20News%20Room&dir=2006/06/07)